ÂÜÀòÂÒÂ×

Tassos Konstantinou is an accomplished executive in the biotechnology and life sciences sectors, currently serving as Managing Director at SPRIM Global Investments since September 2024. Previously, Konstantinou held the position of Managing Director at Arix Bioscience plc and has been involved as a board member for several companies, including Ensoma, Artios, Evommune, Sorriso Pharmaceuticals, Kynos Therapeutics Ltd., and Oxular. With a strong background in investment management as a Life Sciences Investor at IP Group plc, Konstantinou's academic foundation includes a Ph.D. in Molecular Oncology from the University of Oxford and a Bachelor of Science in Biology from Aristotle University of Thessaloniki.